Kessler Foundation

Kessler Foundation Ranks Among Best Nonprofits to Work For in the U.S.

Retrieved on: 
Tuesday, April 2, 2024
Workforce, Rehabilitation, Disability, The NonProfit Times, Employment, Workplace, Kessler Foundation, Research, Philosophy

EAST HANOVER, N.J., April 2, 2024 /PRNewswire/ -- Kessler Foundation, a major nonprofit organization in the field of disability, has placed among the Best Nonprofits to Work For in 2024, a yearly award recognizing the top 50 nonprofits across the U.S.

Key Points: 
  • EAST HANOVER, N.J., April 2, 2024 /PRNewswire/ -- Kessler Foundation, a major nonprofit organization in the field of disability, has placed among the Best Nonprofits to Work For in 2024, a yearly award recognizing the top 50 nonprofits across the U.S.
  • Kessler Foundation, a 501c3 non-profit public charity, is a premier medical research organization with two locations in New Jersey.
  • Nonprofits from across the U.S. entered the two-part survey process to determine the Best Nonprofits to Work For.
  • Kessler Foundation ranked number 16 out of 24 in the medium category (50-249 employees) and number 32 overall.

Research Team Progresses to Final Phase in NIH Competition, Pioneering Autonomic Neuromodulation to Expand Applications for Spinal Stimulation

Retrieved on: 
Thursday, March 21, 2024
Kessler Institute for Rehabilitation, Research, Blood pressure, Reward, Health, TIM, Applied Physics Laboratory, Reynolds Center, Johns Hopkins, SPARC, Learning, Caregiver, News, Rehabilitation, University, Doctor of Philosophy, MD, Quality of life, NIH, Peripheral, Kessler Foundation, Competition, Tetraplegia, Autonomic nervous system, Mobility, Safety, University of Louisville, Neurostimulation, Self-management, Dysautonomia, Bangladesh Technical Education Board, Select Medical, Common Fund for Commodities, Pharmaceutical industry

EAST HANOVER, N.J., March 21, 2024 /PRNewswire/ -- Marking significant progress towards improving the lives of individuals with spinal cord injuries, Kessler Foundation, University of Louisville, and John Hopkins Applied Physics Laboratory (with the support of Medtronic) have collaboratively won the $1,000,000 prize for Phase 2 of the Neuromod Prize for their project titled, "Neuromodulation of the lumbosacral spinal cord for improvement of autonomic function after spinal cord injury." With this win, the team advances to compete for the Phase 3 prize pool of $5 million.

Key Points: 
  • With this win, the team advances to compete for the Phase 3 prize pool of $5 million.
  • Phase 1 called for innovative therapy concepts and development plans, leading to Phase 2's proof-of-concept studies by the eight selected teams.
  • On February 27, 2024, the NIH announced the four Phase 2 victors, marking a breakthrough moment in neuromodulation research.
  • "Most importantly, what we are learning and sharing about neuromodulation through this Competition will influence new approaches to treating other types of disabling autonomic dysfunction."

Wandercraft's self-balancing exoskeleton receives second FDA clearance in less than a year, now indicated for rehabilitation in patients with spinal cord injury

Retrieved on: 
Tuesday, February 13, 2024
CVA, Robotics, SCI, Research, Doctor of Philosophy, Ankle, Atalante, Kessler Foundation, FDA, News, Stroke, TIM, Safety, Tetraplegia, Patient, Neurostimulation, Rehabilitation, Mobility, T5, Gait, Medical device

NEW YORK – 13 February 2024 -- Wandercraft, the developer of the world's first self-balancing robotic exoskeleton that enables people with limited mobility to stand up and walk again, announced today that it has received FDA clearance for Atalante X for rehabilitation in individuals with spinal cord injuries (SCI) at levels T5 to L5.

Key Points: 
  • Matthieu Masselin, CEO of Wandercraft, commented, “Today’s FDA clearance for individuals with spinal cord injuries speaks volumes about the amazing possibilities for Atalante X.
  • The unique ankle motion, combined with intelligent self-balancing technology, means that patients can experience the benefits of once-again walking in a rehabilitation setting.
  • “At Kessler, we are committed to researching promising advances in robotics technology that offer innovative approaches to improving functional recovery.
  • Evaluation of safety and performance of the self balancing walking system Atalante in patients with complete motor spinal cord injury.

MedRhythms Announces Key Publications Confirming Efficacy, Safety, and Usability of InTandem™ for Chronic Stroke Walking Impairment

Retrieved on: 
Thursday, February 8, 2024
Health, Randomized controlled trial, Kessler Foundation, Walking, Johns Hopkins University, American Physical Therapy Association, Preferred walking speed, FDA, Quality of life, Use, University, Nature Communications, Safety, Gait, Control, Risk, Stroke, Boston University, PI, Patient, APTA, Survivor, Neuroscience, Rehabilitation, Research, Doctor of Philosophy, Annual general meeting, AAP, Entrepreneurship, Pharmaceutical industry

Historically, there has been a key care gap in the availability of efficacious walking rehabilitation interventions for the chronic phase of stroke recovery, typically defined as six or more months after the initial stroke.

Key Points: 
  • Historically, there has been a key care gap in the availability of efficacious walking rehabilitation interventions for the chronic phase of stroke recovery, typically defined as six or more months after the initial stroke.
  • There are few interventions that can help people with chronic stroke gait impairment improve both their gait speed and quality.
  • In the randomized controlled trial, study participants with chronic stroke were randomly assigned to InTandem or an active control group.
  • These results confirm InTandem's safety and efficacy for home use by patients living with gait impairment in the chronic stroke recovery phase.

Unprecedented Success Continues: 2023 Employment Gains for People with Disabilities Outshine Those of Counterparts Without Disabilities

Retrieved on: 
Wednesday, January 31, 2024
COVID-19, UNH, Growth, COVID, BLS, Employment, Kessler Foundation, Economics, IOD, Doctor of Philosophy, University, Tutoring

EAST HANOVER, N.J., Jan. 30, 2024 /PRNewswire/ -- Amidst the backdrop of a remarkable four-year streak of growth, the employment indicators for people with disabilities reached unprecedented milestones in 2023. This achievement stands in stark contrast to the experiences of people without disabilities who faced a more severe decline during the COVID-19 pandemic and a slower recovery, not surpassing their pre-pandemic employment levels until 2023. That's according to the National Trends in Disability Employment (nTIDE) 2023 Year-End Special Edition, issued by Kessler Foundation and the University of New Hampshire's Institute on Disability (UNH-IOD), based on data from the U.S. Bureau of Labor Statistics (BLS) Jobs Reports.

Key Points: 
  • EAST HANOVER, N.J., Jan. 30, 2024 /PRNewswire/ -- Amidst the backdrop of a remarkable four-year streak of growth, the employment indicators for people with disabilities reached unprecedented milestones in 2023.
  • "How have they achieved these gains when people without disabilities are only now reaching their pre-pandemic level?
  • Throughout 2023, nTIDE experts analyzed the contribution of various sub-populations to these historic employment gains for people with disabilities in monthly "Deeper Dive" Lunch & Learn webinars.
  • "Clearly, the upward trend for employment for people with disabilities is broad-based," he added.

ONWARD® ARC Therapy™ Highlighted at 2024 Annual Meeting of the North American Neuromodulation Society (NANS)

Retrieved on: 
Thursday, January 25, 2024
BCI, Assistant, Spinal cord injury, ARC, Euronext, Spinal cord, NANS, Neuromodulation, DSM-IV codes, University, Kessler Foundation, SCI, De novo, Movement, Paralysis, Neurology, FDA, Chronic pain, Abstract, Medical device

The Up-LIFT pivotal study investigated non-invasive neuromodulation to improve upper extremity strength and function after SCI; ARC-EX Therapy met all primary safety and effectiveness endpoints and demonstrated a 72% responder rate1.

Key Points: 
  • The Up-LIFT pivotal study investigated non-invasive neuromodulation to improve upper extremity strength and function after SCI; ARC-EX Therapy met all primary safety and effectiveness endpoints and demonstrated a 72% responder rate1.
  • While bringing awareness to spinal cord injury during a meeting traditionally focused on chronic pain and movement disorders, Dr.
  • Guest presented clinical results and his experience from the Up-LIFT pivotal study.
  • All ONWARD devices and therapies, including but not limited to ARC-IM®, ARC-EX, and ARC Therapy, alone or in combination with BCI, are investigational and not available for commercial use.

Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations

Retrieved on: 
Tuesday, November 7, 2023
Robotics, Medical Devices, Health, Technology, Health Technology, General Health, Insurance, Louis Stokes, Growth, Centers for Medicare & Medicaid Services, PIN, HCPCS, International, Medicare, Foundation (nonprofit), Government Accountability Office investigations of the Department of Defense, EBITDA, Medicare Advantage, DME, ASP, Publication, GAAP, Advertising, Research, Medicare Part D, Care Health Insurance, Edward Hines Jr. Veterans Administration Hospital, Healthcare Common Procedure Coding System, Webcast, Medicare (United States), United States Department of Veterans Affairs, Classification, Table, Investment, Defense, Kessler Foundation, Patient, CMS, Video game, Health insurance

Excluding guaranteed minimum payment revenue from the China JV company, product revenue was $5.0 million, up 27% compared with the third quarter of 2022.

Key Points: 
  • Excluding guaranteed minimum payment revenue from the China JV company, product revenue was $5.0 million, up 27% compared with the third quarter of 2022.
  • Myomo recognized revenue on 119 MyoPro units in the third quarter of 2023, up 37% over the same quarter a year ago.
  • Gross margin for the third quarter of 2023 was 68.7%, compared with 66.5% for the third quarter of 2022.
  • Operating expenses for the third quarter of 2023 were $5.5 million, an increase of 1% over the third quarter of 2022.

Wandercraft announces launch of US commercial operations with the start of Atalante X research at Kessler Foundation

Retrieved on: 
Thursday, October 12, 2023
Partnership, Walking, National Multiple Sclerosis Society, Mobility, Engineering, Doctor of Philosophy, Gait, TIM, Stroke, Research, Rehabilitation, European Economic Area, ALS, Human, Freedom, Brain damage, FDA, Movement, European Union Centers of Excellence in the United States, Disability, Neurostimulation, CE, EEA, Multiple sclerosis, Kessler Foundation, Korea Disease Control and Prevention Agency, Patient, Tetraplegia, Management, Medical device, Nursing, EU

NEW YORK CITY, New York, 12 October 2023 -- Wandercraft, the developer of the world's first self-stabilizing walking exoskeleton, designed to enable people with walking impairments to stand and walk again, announced today the official launch of commercial operations in the United States with the start of Atalante X research at Kessler Foundation, a global leader in rehabilitation research.

Key Points: 
  • A large number of individuals with disabilities in the US may benefit from using the Atalante X exoskeleton.
  • In addition, approximately 302,000 people living in the United States have experienced a traumatic spinal cord injury according to the US National Spinal Cord Injury Statistical Center.
  • Finally, approximately one million people in the US are living with multiple sclerosis according to the National Multiple Sclerosis Society.
  • The CE marking represents a manufacturer's declaration that products comply with the EU's New Approach Directives.

New Online Course Equips Personal Care Assistants with Essential Knowledge for Supporting Individuals with Spinal Cord Injury

Retrieved on: 
Tuesday, August 15, 2023
Blood pressure, Rehabilitation Research and Development Service, MPT, Institutional review board, Tetraplegia, Paralyzed Veterans of America, Partnership, National Institute on Disability, Independent Living, and Rehabilitation Research, Spinal cord, Quality of life, Muscular Dystrophy Community Assistance Research and Education Amendments of 2001, United States Secretary of Labor, Rehabilitation, Spinal cord injury, Doctor of Philosophy, Wheelchair, The Foundation for Young Australians, NIDILRR, Focus group, Sam Schmidt Paralysis Foundation, Kessler Foundation, Shepherd Center, Disability, Independent living, Elevate, PVA, EAST, Knowledge, Collaboration, Grant, Education, Caregiver, Trapping, Nursing, Research

EAST HANOVER, N.J., Aug. 15, 2023 /PRNewswire/ -- A new interactive, online course, "Understanding Spinal Cord Injury: A Course for Personal Care Assistants," was designed to enhance the training of personal care assistants (PCAs) for individuals with spinal cord injury. The course was unveiled today at the Paralyzed Veterans of America Healthcare (PVA) Summit + Expo at the Renaissance Orlando at SeaWorld Hotel in Orlando, FL. The presentation was given by Jeanne Zanca, MPT, PhD, FACRM, assistant director of the Center for Spinal Cord Injury Research at Kessler Foundation and chair of the Foundation's Institutional Review Board.

Key Points: 
  • Launch of "Understanding Spinal Cord Injury: A Course for Personal Care Assistants," is an important step toward ensuring quality personal care assistance services for individuals with spinal cord injury
    EAST HANOVER, N.J., Aug. 15, 2023 /PRNewswire/ -- A new interactive, online course, " Understanding Spinal Cord Injury : A Course for Personal Care Assistants," was designed to enhance the training of personal care assistants (PCAs) for individuals with spinal cord injury.
  • Elevate training for personal care assistants with free, interactive online course: Understanding Spinal Cord Injury
    The course, the first specifically designed to introduce personal care assistants to spinal cord injury, is available at no cost at https://www.kflearn.org , the Foundation's site for educational and training resources for consumers and professionals.
  • Recognizing its focus on client-centered care for spinal cord injury, the North American Spinal Cord Injury Consortium (NASCIC) has endorsed the new course.
  • "Understanding Spinal Cord Injury: A Course for Personal Assistants," is a significant step towards ensuring the quality of personal care assistance services provided to individuals living with spinal cord injury," Dr. Zanca emphasized.

Kessler Foundation Maintains Ranking Among 'NJBIZ' 2023 Best Places to Work in NJ'

Retrieved on: 
Wednesday, July 19, 2023
Cognition, Disability, Workplace, Stroke, Provident Credit Union Event Center, Rehabilitation, Research, Freehold, Multiple sclerosis, Kessler Foundation, Traumatic brain injury, Spectrum, DeRose, Nursing, Management

EAST HANOVER, N.J., July 19, 2023 /PRNewswire/ -- Kessler Foundation, a major nonprofit organization in the field of disability rehabilitation, was named one of NJBIZ' 2023 Best Places to Work in New Jersey. The Foundation also won this award in 2022 and a number of previous years, dating back to 2012. The prestigious award program is dedicated to identifying and honoring the state's top employers that show dedication to their employees' professional and personal development.

Key Points: 
  • EAST HANOVER, N.J., July 19, 2023 /PRNewswire/ -- Kessler Foundation , a major nonprofit organization in the field of disability rehabilitation, was named one of NJBIZ' 2023 Best Places to Work in New Jersey.
  • The Foundation also won this award in 2022 and a number of previous years, dating back to 2012.
  • The Foundation was ranked among the Best Places to Work in New Jersey in the medium-sized category (15-249 employees) by NJBIZ.
  • For a complete list of the 2023 Best Places to Work in New Jersey honorees, visit: https://njbiz.com/new-jerseys-best-places-to-work-2023/ .